Cite
HARVARD Citation
Korkmaz, T. et al. (2016). Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials. Critical reviews in oncology/hematology. pp. 180-188. [Online].